1 not yet recruiting, 1 unknown. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 1, Unknown 1 |
Follow Lansoprazole 15 mg: new trials by email Literature Review of Lansoprazole 15 mg trials Research Report on Lansoprazole 15 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer Fexuprazan 20mg, Lansoprazole 15 mg placebo, Lansoprazole 15 mg - NSAID (Non-Steroidal Anti-Inflammatory Drug) | Phase 4 | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | 360 | 2026-04-01 | 2026-04-16 |
| The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole) Lansoprazole 15 mg - Coronary Artery Disease | Phase 4 | Unknown | Daejeon St. Mary's hospital | 300 | 2023-05-01 | 2023-04-19 |
Daejeon St. Mary's hospital (1) · Daewoong Pharmaceutical Co. LTD. (1)
South Korea (1)
DaeWon Kim (1)
PMID 11519503, PMID 15758000, PMID 20925534, PMID 21126648, PMID 22249527, PMID 22688850, PMID 25286881, PMID 26751904, PMID 28886622, PMID 30522654, PMID 30851041, PMID 31152740